Dr. Jayanth Koneru, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 21
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 1,338
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
FL license ME124094 -
Internal Medicine Physician
AL license 29796
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Adventhealth Ocala Ocala, FL
- Marion Communtiy Hospital Ocala, FL
Medical groups
- Cardiovascular Institute of Central Florida LLC (69 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,338
- Services billed
- 7,317
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,503 | 710 |
| Injection, regadenoson, 0.1 mg | 1,320 | 330 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 638 | 319 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 581 | 569 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 371 | 346 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 331 | 331 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 327 | 208 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 319 | 319 |
| Nuclear medicine study of heart muscle blood flow by pet | 317 | 317 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 314 | 304 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Ocala, FL | 517 |
| Entresto (sacubitril/valsartan) Other prescribers in Ocala, FL | 373 |
| Atorvastatin Calcium Other prescribers in Ocala, FL | 285 |
| Losartan Potassium Other prescribers in Ocala, FL | 278 |
| Metoprolol Tartrate Other prescribers in Ocala, FL | 242 |
| Xarelto (rivaroxaban) Other prescribers in Ocala, FL | 239 |
| Metoprolol Succinate Other prescribers in Ocala, FL | 234 |
| Amlodipine Besylate Other prescribers in Ocala, FL | 204 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Ocala, FL | 188 |
| Nifedipine Er (nifedipine) Other prescribers in Ocala, FL | 181 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 19 payments worth $12,129 in total to this clinician.
| Amgen Inc. | $11,818 |
|---|---|
| Abbott Laboratories | $153 |
| Pfizer Inc. | $47.89 |
| Philips North America LLC | $34.84 |
| AstraZeneca Pharmaceuticals LP | $21.82 |
| Impulse Dynamics (USA) Inc. | $20.89 |
| Merck Sharp & Dohme LLC | $16.80 |
| E.r. Squibb & Sons, L.l.c. | $15.33 |
| Compensation for services other than consulting (speaking, faculty) | $11,200 |
|---|---|
| Food and Beverage | $929 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) Repatha · Cardiovascular | $2,800 |
| Amgen Inc. Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) Repatha · Cardiovascular | $2,800 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.